CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy
Authors
Keywords
-
Journal
BMC CANCER
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-03
DOI
10.1186/s12885-019-6353-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Differential expression and function of CAIX and CAXII in breast cancer: A comparison between tumorgraft models and cells
- (2018) Zhijuan Chen et al. PLoS One
- Evaluation of metabolomic changes during neoadjuvant chemotherapy combined with bevacizumab in breast cancer using MR spectroscopy
- (2017) Leslie R. Euceda et al. Metabolomics
- Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses
- (2016) Yaewon Yang et al. BMC CANCER
- Performance and Practice Guideline for the Use of Neoadjuvant Systemic Therapy in the Management of Breast Cancer
- (2015) Dennis Holmes et al. ANNALS OF SURGICAL ONCOLOGY
- International Variation in Female Breast Cancer Incidence and Mortality Rates
- (2015) C. E. DeSantis et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?
- (2015) Qian Wang-Lopez et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival
- (2015) Franziska Baenke et al. JOURNAL OF PATHOLOGY
- Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors
- (2015) Céline Pinheiro et al. Oncotarget
- The Global Burden of Cancer 2013
- (2015) Christina Fitzmaurice et al. JAMA Oncology
- Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome
- (2014) J. Doyen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Carbonic anhydrase 9 is associated with chemosensitivity and prognosis in breast cancer patients treated with taxane and anthracycline
- (2014) Naoki Aomatsu et al. BMC CANCER
- Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells
- (2014) Lāsma Ivanova et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- XB130 promotes proliferation and invasion of gastric cancer cells
- (2014) Min Shi et al. Journal of Translational Medicine
- Garbage in, garbage out: A critical evaluation of strategies used for validation of immunohistochemical biomarkers
- (2014) Gillian O'Hurley et al. Molecular Oncology
- Prognostic significance of pathologic complete response and Ki67 expression after neoadjuvant chemotherapy in breast cancer
- (2013) Tatsuya Yoshioka et al. Breast Cancer
- Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification
- (2012) A S Betof et al. BRITISH JOURNAL OF CANCER
- Role of monocarboxylate transporters in human cancers: state of the art
- (2012) Céline Pinheiro et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
- (2012) Gunter von Minckwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- The manufacture and assessment of tissue microarrays: suggestions and criteria for analysis, with breast cancer as an example
- (2012) Sarah E Pinder et al. JOURNAL OF CLINICAL PATHOLOGY
- Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4
- (2011) Saskia E Rademakers et al. BMC CANCER
- A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response
- (2011) Oscar Krijgsman et al. BREAST CANCER RESEARCH AND TREATMENT
- Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials
- (2010) Gunter von Minckwitz et al. BREAST CANCER RESEARCH AND TREATMENT
- Immunohistochemical surrogate markers of breast cancer molecular classes predicts response to neoadjuvant chemotherapy
- (2010) Rohit Bhargava et al. CANCER
- Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma
- (2010) Céline Pinheiro et al. HISTOPATHOLOGY
- Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer
- (2010) Johanna Chiche et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response
- (2009) Jorma J. de Ronde et al. BREAST CANCER RESEARCH AND TREATMENT
- Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas
- (2008) Céline Pinheiro et al. VIRCHOWS ARCHIV
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started